Thymalin

Research Phase

Thymalin (Thymic Polypeptide Complex)

Aliases
Thymaline, TP-1
Administration
Intramuscular injection

Research and regulatory

Development stage

Studied in Russian clinical research since the 1970s-80s for immune restoration; not FDA reviewed.

Legal and regulatory

Approved prescription drug in Russia; not FDA approved or reviewed in the United States.

Side effects

Generally well-tolerated in Russian clinical studies